CTX Lifescience Pvt Ltd
PMDA      
US FDA INSPECTED & COMPLIANT   
EU GMP CERTIFIED   
PMDA JAPAN ACCREDITATION   
Pharma Products
 
API - Under Development
Sr. No Product Name Therapeutic Category R & D Sample Method Devp Validation Status
1. Apixaban Anti-coagulant     Q3 2016
2. Dorzolamide Hydrochloride Anti-glaucoma     Q3 2016
3. Brexpiprazole Dihydrochloride Anti-schizophrenic     Q3 2016
4. Alogliptin Benzoate Anti-diabetic     Q4 2016
5. Flibanserin For treatment of HSDD     Q4 2016
6. Sofosbuvir Anti-retroviral     Q1 2017
CTX Life Sciences Pvt. Ltd. respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API / Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.